Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Personalized, multidisciplinary care improves skin condition management and patient outcomes.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

SH-MSCs gel reduced IL-6 and increased TGF-β, suggesting it could treat alopecia.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.

Pregnancy can cause skin changes and issues that need careful management.

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Removing both KLK5 and KLK7 proteins can prevent death and skin issues in Netherton syndrome.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Mechanical stretching of the skin can promote hair growth by activating certain immune cells.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.

Transplant success has improved with better immunosuppressive drugs and donor matching.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Stress can stop hair growth in mice, and treatments can reverse this effect.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.